|This article needs additional citations for verification. (June 2007)|
|Systematic (IUPAC) name|
|(what is this?)|
As an analogue of prostacyclin PGI2, beraprost affects vasodilation, which in turn lowers blood pressure. Beraprost also inhibits platelet aggregation, though the role this phenomenon may play in relation to pulmonary hypertension has yet to be determined.
Dosage and administration
Beraprost is administered orally as a pill.
|This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.|